Active Not RecruitingNCT04711915

Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

Medication studyAges 21–65United StatesDepression

The study in practice

Understand this study

Listed age limits: 21 years to 65 years.

Listed locations: West Haven, United StatesSee all locations and recruitment
Activities: Medication described in the protocol
Compensation: Payment and expense reimbursement have not been verified.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: March 17, 2021

Recruitment status: Active Not Recruiting
Enrollment listed in the registry: 30
Sponsor: Yale University
Sponsor type: University
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 1
Locations: United States
Age range: From 21 Years to 65 Years
Official registry ID: NCT04711915
Official title: Show the full official title
Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

The HopeStage team will email you.

Not recruiting

West Haven

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Yale University, a university.

Does this study involve medication?

Yes. The study involves medication, including 0.1 mg/kg Dimethyltryptamine (DMT) and 0.3 mg/kg Dimethyltryptamine (DMT).

Who can participate?

Listed age limits: 21 years to 65 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.